Editorial Team

The management of our journal is a collaborative endeavor by the whole editorial team, featuring an active, widely respected, diverse, and representative Editorial Board. The editorial structure of the journal is listed as below and the roles and responsibilities of the editorial team are available at: https://www.amegroups.com/pages/journal-management#content-title.

Editors-in-Chief

Yongshui Fu, MD, PhD

Guangzhou Blood Center, Guangzhou, China; Guangzhou First People's Hospital, Guangzhou, China

Huaqin Liang, MD

Guangzhou Blood Center, Guangzhou, China

Associate Editors-in-Chief

Chengyao Li, PhD

Department of Transfusion Medicine, Southern Medical University, Guangzhou, China

Paul D. Mintz, MD

Editorial Board

Jean-Pierre Allain, MD, PhD, FRCPath

Department of Haematology, University of Cambridge, Cambridge, UK

Carine Prisco Arnoni, PhD

Technical Scientific Department, Colsan – Associação Beneficente de Coleta de Sangue, São Paulo, SP, Brazil

Shebli Atrash, MD, MS, FACP

Department of Hematologic Oncology and Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, NC, USA

Evan M Bloch, MD, MS

Johns Hopkins University School of Medicine, Department of Pathology, Baltimore, USA

Thierry Burnouf, PhD

Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei

Daniel Candotti, PhD

Department of Virology, Henri Mondor Hospital, Paris-Est University, INSERM U955-IMRB-Team 18, 94010 Creteil, France

Lilian Castilho, PhD

University of Campinas, Hemocentro Unicamp, Campinas, SP, Brazil

Joan Cid, MD, PhD

Department of Hemotherapy and Hemostasis, ICMHO, Hospital Clinic, Villarroel, Barcelona, Catalonia, Spain

Frederik Banch Clausen, MSc, PhD, DMSc

Senior Research Scientist, Laboratory of Blood Genetics, Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark

Philip Crispin

School of Medicine and Psychology, Australian National University, Canberra, Australia; Haematology Department, Canberra Hospital, Canberra, Australia

Gregory A. Denomme, PhD, FCSMLS(D)

Grifols Laboratory Solutions, San Marcos, Texas, USA

Robert A. DeSimone, MD

Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA

William B. Ershler, MD

Department of Hematology, Inova Schar Cancer Institute, Fairfax, Virginia, USA

Helen Faddy, PhD, BSc(Hons)

School of Health and Sports Science, University of the Sunshine Coast, Brisbane, Queensland, Australia

Yann Fichou, PhD

Etablissement français du sang (EFS) – Bretagne, Brest, France; UMR1078 Genetics, functional Genomics and Biotechnology (GGB) – Inserm, EFS, UBO – Brest, France

Robert Flower, PhD, FFSc (RCPA)

Research and Development, Australian Red Cross Blood Service, Brisbane, Australia; School of Biomedical Science, Faculty of Health, Queensland University of Technology, Brisbane, Australia

Massimo Franchini, MD

Department of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantua, Italy

Mark T. Friedman, DO

NYU Langone Hospital-Long Island, NYU Grossman Long Island School of Medicine, Mineola, New York, USA

Yoke Lin Fung

School of Health and Behavioural Sciences, University of the Sunshine Coast, Queensland, Australia

Konstantine Halkidis, MD, PhD

Division of Hematologic Malignancies and Cellular Therapeutics, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA

Ping Hui, MD, MPA

Macau Blood Transfusion Service, Macau, Special Administrative Region of China

Rick Kapur, MD, PhD, MSc

Department of Experimental Immunohematology, Sanquin Research, and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands

Cheuk Kwong LEE

Hong Kong Red Cross Blood Transfusion Service, Hong Kong, China

Kenrad E. Nelson, MD

Johns Hopkins University Medical Institutions, Baltimore, MD, USA

Paul M. Ness, MD

Division of Transfusion Medicine, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

Heyu Ni, MD, PhD

Department of Laboratory Medicine and Pathobiology Department of Medicine, and Department of Physiology University of Toronto, Toronto, Canada

Huy P. Pham, MD, MPH

National Marrow Donor Program (NMDP), Minneapolis, Minnesota, USA; Seattle Apheresis Collection Center, Seattle, Washington, USA

Osvaldo Padilla, MD, MPH

Department of Pathology, Texas Tech University Health Science Center, El Paso, TX, USA

Anthony E. Pusateri, PhD

Science and Technology Directorate, 59th Medical Wing, JBSA-Lackland Air Force Base, San Antonio, Texas, USA

Sentot Santoso, MD

Institute for Clinical Immunology and Transfusion Medicine, Justus Liebig University, Giessen, Germany

John W. Semple, PhD

Division of Hematology and Transfusion Medicine, Lund University, Lund, Sweden

Hua Shan, MD, PhD

Transfusion Medicine Service at Stanford University Medical Center, Stanford, CA, USA

Pilar Solves, MD, PhD

Blood Bank, Hematology Service, Hospital Universitari I Politècnic la Fe, Valencia, Spain; CIBERONC, Instituto Carlos III, Madrid, Spain

Minh-Ha Tran, DO, CABP

Irvine Department of Pathology and Laboratory Medicine, University of California, Orange, CA, USA

Nelson Hirokazu Tsuno, MD, PhD, MBA

The Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Tokyo, Japan

John-Paul Tung

Research and Development, Australian Red Cross Lifeblood, Brisbane, Queensland, Australia; Faculty of Health, Medicine and Behavioural Sciences, University of Queensland, Brisbane, Queensland, Australia; School of Health, University of the Sunshine Coast, Sippy Downs, Queensland, Australia; Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia; Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia